Glucon

company

About

Glucon is a development stage company developing glucose monitoring devices for the diabetes market.

  • 1 - 10

Details

Last Funding Type
Series A
Last Funding Money Raised
$13M
Industries
Medical,Medical Device
Founded date
Jan 1, 2000
Number Of Employee
1 - 10
Operating Status
Active

Glucon is a development stage company developing glucose monitoring devices for the diabetes market. The Glucon devices will provide continuous, accurate, and real-time glucose monitoring, for clinical and personal use. Glucon devices are based on a novel Photoacoustic (optical and sound-based) technology protected by several granted
and pending patents, and intended to be incorporated into a small, conveniently wearable instrument (the Personal Device).

The company has shown that Photoacoustics, a unique combinatorial technology, is superior to optics alone, as it attains blood glucose measurements directly from inside the blood vessels and is an improved method both for specificity (identification) and sensitivity (detection of level changes) of the glucose measurement.

The company’s desktop prototype device is currently undergoing extensive clinical trials.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$13M
Glucon has raised a total of $13M in funding over 2 rounds. Their latest funding was raised on Jan 7, 2004 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 7, 2004 Series A $13M 1 Innomed Ventures Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Glucon is funded by 1 investors. Innomed Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Innomed Ventures Yes Series A